A critical issue in modern cancer research is how diversity, both genetic and non-genetic, influences tumor progression and response to therapy. The Center for Cancer Systems Biology (CCSB) at MSKCC assembles a consortium of investigators who integrate computational and experimental strategies to investigate diversity in cancer at the level of individual cells, tumor microenvironment, and patients. The research program for this CCSB is organized into four inter-related subprojects. (I) We study the variability of cellular responses to growth factors and drugs during tumorigenesis, using competition for the growrth factor IL-6 in melanoma and breast cancer cells as a model system. We use computational modeling ofthe dynamics ofthe IL-6 pathway in order to optimize new chemotherapeutic protocols that rely on cellular diversity to maximize tumor cytotoxicity. (II) We use expression profiling of protease networks in both tumor and stromal cells and genome-wide profiling of subpopulations of tumor-associated macrophages to learn predictive statistical models of tumor-stromal cell interactions. We also use agent-based computational models to simulate cancer-cell macrophage interactions. Computational predictions will be validated with in vitro and in vivo experiments. (Ill) We focus on predictive network models of differences in signaling information flow in distinct tumor subtypes. Using the results of systematic drug perturbation experiments, we will design Hopfield network models based on non-linear differential equations to decipher the differences in signaling networks between primary glioblastoma subtypes and to investigate the changes in network dynamics during the evolution of drug resistance. (IV) We study the endogenous diversity of B cell signaling pathways in Chronic Lymphocytic Leukemia (CLL) patients. We will generate biochemical models of signaling pathways to identify key signaling regulators whose variation in expression predicts functional heterogeneity, validate the predictions with single-cell profiling, and define a new set of functional markers to better characterize disease progression. By elucidating the consequences of diversity in cancer, this research will ultimately guide the development of new cancer therapies.

Public Health Relevance

The MSKCC CCSB is an interdisciplinary team of investigators with strong clinical links who will use novel 9xperimental-computational methods in systems biology to investigate diversity in cancer at the level of cells, :issues and patients. The research program supports the public health goals ofthe ICBP of NCI through its jitimate impact on the development of new cancer therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA148967-04
Application #
8468129
Study Section
Special Emphasis Panel (ZCA1-SRLB-C (J1))
Program Officer
Gallahan, Daniel L
Project Start
2010-05-01
Project End
2015-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
4
Fiscal Year
2013
Total Cost
$2,702,738
Indirect Cost
$1,281,853
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Korolev, Kirill S; Xavier, Joao B; Gore, Jeff (2014) Turning ecology and evolution against cancer. Nat Rev Cancer 14:371-80
Palomba, M Lia; Piersanti, Kelly; Ziegler, Carly G K et al. (2014) Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells. PLoS One 9:e79987
Sevenich, Lisa; Joyce, Johanna A (2014) Pericellular proteolysis in cancer. Genes Dev 28:2331-47
Sevenich, Lisa; Bowman, Robert L; Mason, Steven D et al. (2014) Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol 16:876-88
Pyonteck, Stephanie M; Akkari, Leila; Schuhmacher, Alberto J et al. (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264-72
Chang, Qing; Bournazou, Eirini; Sansone, Pasquale et al. (2013) The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia 15:848-62
Gauthier, Nicholas P; Soufi, Boumediene; Walkowicz, William E et al. (2013) Cell-selective labeling using amino acid precursors for proteomic studies of multicellular environments. Nat Methods 10:768-73
Tkach, Karen; Altan-Bonnet, Gregoire (2013) T cell responses to antigen: hasty proposals resolved through long engagements. Curr Opin Immunol 25:120-5
Cotari, Jesse W; Voisinne, Guillaume; Dar, Orly Even et al. (2013) Cell-to-cell variability analysis dissects the plasticity of signaling of common ? chain cytokines in T cells. Sci Signal 6:ra17
Nadell, Carey D; Bucci, Vanni; Drescher, Knut et al. (2013) Cutting through the complexity of cell collectives. Proc Biol Sci 280:20122770

Showing the most recent 10 out of 14 publications